Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

The Effects of Cancer on Family Life

Pediatric Cancer

Cancer History

Extracellular Vesicles as Floating Cancer Biomarkers

Living with Cancer Pain

What is Cancer?

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

The Cancer Cell Surface Proteome as a Therapeutic Target

Myc Mutations and Cancer

What is the Tumor Microenvironment?

Cancer Pain Management

See more featured articles »

Secondary Brain Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Symptoms

TARDIS: The Improved Method of Detecting Breast Cancer

CDK9 and Cancer

Investigating the Molecular Mechanisms of Cancer

What Role do Biobanks Play in Cancer Research?

Exploiting Enzymes in Cancer Diagnosis and Therapy

Transforming Cancer Care through Genomic Testing

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Effects of Social and Economic Deprivation on Cancer Mortality

What is Tumorigenesis?

British Pioneers in Cancer Biology

Caring for a Loved One with Cancer

Assay for Monitoring and Treating Malignant Brain Tumors

What is Immunochemotherapy?

Cancer Pain

Is Cancer a Metabolic Disorder?

The Biochemistry of Breast Cancer Screening

Cancer Diagnosis

Hypoxia Markers and Their Importance

Microfluidic cancer treatment screen combined with flow cytometry

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Insights into Oncofertility

Cutaneous Manifestations of Internal Malignancy

Cancer Screening Considerations: Balancing the Benefits and Risks

Overview of Cell Viability and Cytotoxicity

Using Biomarkers to Detect Cancer

Cancer Epidemiology

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Management

Cancer Prognosis

Cancer Pathophysiology

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

What Causes Cancer?

What is Merkel Cell Carcinoma?

Cancer Classification

Hot vs Cold: the differences between tumor types

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Insight into Cancer Vaccines

Cancer Glossary

Secondary Lung Cancer

Metastatic Migration in Cancer may be Influenced by Metabolism

Why are Cancer Cell Lines Useful?

Targeted Cancer Therapies

Cancer Prevention: Lowering your Risk

What is Cancer of Unknown Primary?

Acidosis and Tumor Progression

Cancer Research

Latest Cancer News and Research

Precision medicine tools offer hope for patients with rare blood cancers

Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas—blood cancers that arise in immune cells called B cells—yet the same is not true for patients with more rare lymphoma types that originate in immune cells called T cells.

9 Apr 2026

OICR funds four Ontario teams to develop next-generation cancer therapies

Better cancer care depends on better treatment options. That's why the Ontario Institute for Cancer Research (OICR) is supporting four Ontario-based research teams working to develop the next generation of cancer therapies that are designed to be more effective at destroying tumors, have reduced side effects, and make cancer less likely to return.

9 Apr 2026

UVA scientists develop AI tools to accelerate new drug discovery

University of Virginia School of Medicine scientists have developed a bold new approach to drug development and discovery that could dramatically accelerate the creation of new medicines.

9 Apr 2026

Study explains why current BET inhibitors fail in cancer treatment

For over a decade, a class of drugs called BET inhibitors has been tested in cancer trials with high expectations.

9 Apr 2026

Farm bureau plans are a less pricey alternative to ACA coverage — with trade-offs

Robin Carlton pays about $650 a month for a plan on the Missouri health insurance exchange that covers him and his two teenage kids.

9 Apr 2026

Microplastics found in human bile may be associated with gallstones

Findings show microplastics in bile may trigger cellular senescence, suggesting a link to gallstone disease and highlighting the need for further research.

9 Apr 2026

Study reveals lung-brain link between smoking and neurodegeneration

The correlation between smoking and neurodegeneration is well-documented, with one study from 2011 finding heavy smoking in midlife was associated with a greater than 100% increase in risk of dementia, Alzheimer's and vascular dementia more than two decades later.

8 Apr 2026

High-quality plant-based diets linked to lower dementia risk

Eating a higher quality plant-based diet is associated with a lower risk of Alzheimer's disease and other related dementias compared to eating a lower quality plant-based diet, according to a study published April 8, 2026, in Neurology, the medical journal of the American Academy of Neurology.

8 Apr 2026

New method reveals how the genome is regulated and disrupted in diseases

Researchers at the University of Minnesota Medical School have developed a new method called PARTAGE that provides a clearer picture of how the genome is regulated and disrupted in diseases like cancer.

8 Apr 2026

Stem cell study identifies universal checkpoint controlling cell identity

A study published in Cell Research advances a central idea in stem cell biology by identifying a checkpoint that controls the identity of many different types of stem cells across developmental stages.

8 Apr 2026

Sponge and sea slug partnership yields a new anticancer molecule with drug design promise

Researchers identified jorumycidine, a new hexacyclic marine alkaloid from the nudibranch Jorunna funebris and its dietary sponge, Haliclona sp., and demonstrated that it exhibits potent nanomolar cytotoxicity against multiple myeloma cells. They also proposed a new biosynthetic route involving cross-species metabolic interplay and an unusual oxazolidine ring that may help stabilize a pharmacologically important scaffold.

8 Apr 2026

Why early-onset cancers are rising and how researchers plan to stop them

Early-onset cancers are rising worldwide, and this Cell Perspective argues that cancer prevention must move beyond static risk-factor snapshots toward life-course exposure mapping, tissue-level biology, and dynamic estimates of preventability. The authors propose three linked frameworks to speed discovery of cancer causes and translate those findings into more precise prevention and interception strategies.

8 Apr 2026

Genetic overlap links psychiatric disorders with many physical ailments

For centuries, mental illness and physical disease have been viewed as two distinct categories, each with its own field of study, its own doctors, and its own menu of treatments.

8 Apr 2026

Study outlines principles for using CAR immunotherapies to treat neurodegenerative diseases

A UAB research team defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials, which are still at a very preliminary stage, in a review study published in the journal Trends in Pharmacological Sciences.

8 Apr 2026

Insilico Medicine nominates AI-driven drug candidate for cancer, Cushing's syndrome and obesity

The NR3C1 (nuclear receptor subfamily 3 group C member 1) gene encodes the glucocorticoid receptor (GR), a nuclear receptor vital for maintaining physiological homeostasis, and inhibition of NR3C1 could increase the sensitivity of cancer cells to standard chemotherapy, particularly in ovarian cancer.

8 Apr 2026

Never married adults face higher risk of developing cancer

Adults who have never been married face a significantly higher risk of developing cancer than those who have been married, according to a large U.S. study of more than 4 million cases.

8 Apr 2026

New clinical guidelines address blood clot prevention in pediatric patients

The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) released comprehensive clinical practice guidelines on anticoagulant prophylaxis in non-cardiac pediatric patients at risk of venous thromboembolism (VTE).

8 Apr 2026

Clusterin inhibition offers new hope for treating cervical gastric-type adenocarcinoma

Gastric-type adenocarcinoma (GAS) is one of the most aggressive non-human papillomavirus (HPV)-associated cervical adenocarcinomas and remains especially difficult to diagnose and treat.

8 Apr 2026

Study reveals how hyperdiploidy creates rare pre-leukemic clones in children

B-cell acute lymphoblastic leukemia is the most common form of childhood cancer. In this type of cancer, which affects blood cells, one of the most common abnormalities is the presence of cells with an excess of chromosomes (hyperdiploidy), a condition that leads to chromosomal instability.

8 Apr 2026

Future CAR therapy expands beyond T cells to treat diverse diseases

CAR-T therapy has transformed treatment for some blood cancers, with seven FDA-approved products and strong clinical responses in hematologic malignancies.

8 Apr 2026